AN + AD in Early cHL
Phase II Study of Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine in Early-Stage Classical Hodgkin Lymphoma

Released: December 13, 2023

Activity

Progress
1
Course Completed